Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern

Livermore, 2003, Bacterial resistance: origins, epidemiology, and impact, Clin Infect Dis, 36, S11, 10.1086/344654

Bradford, 2001, Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat, Clin Microbiol Rev, 14, 933, 10.1128/CMR.14.4.933-951.2001

Paterson, 2005, Extended-spectrum β-lactamases: a clinical update, Clin Microbiol Rev, 18, 657, 10.1128/CMR.18.4.657-686.2005

Jacoby, 2005, The new β-lactamases, N Engl J Med, 352, 380, 10.1056/NEJMra041359

Talbot, 2006, Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America, Clin Infect Dis, 42, 657, 10.1086/499819

Canton, 2006, The CTX-M β-lactamase pandemic, Curr Opin Microbiol, 9, 466, 10.1016/j.mib.2006.08.011

Bonnet, 2004, Growing group of extended-spectrum β-lactamases: the CTX-M enzymes, Antimicrob Agents Chemother, 48, 1, 10.1128/AAC.48.1.1-14.2004

Livermore, 2007, CTX-M: changing the face of ESBLs in Europe, J Antimicrob Chemother, 59, 165, 10.1093/jac/dkl483

Pitout, 2005, Community-wide outbreaks of clonally related CTX-M-14 β-lactamase-producing Escherichia coli strains in the Calgary Health Region, J Clin Microbiol, 43, 2844, 10.1128/JCM.43.6.2844-2849.2005

Walther-Rasmussen, 2004, Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum β-lactamases, Can J Microbiol, 50, 137, 10.1139/w03-111

Pitout, 2005, Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community, J Antimicrob Chemother, 56, 52, 10.1093/jac/dki166

Rodriguez-Bano, 2004, Epidemiology and clinical features of infections caused by extended-spectrum β-lactamase-producing Escherichia coli in nonhospitalized patients, J Clin Microbiol, 42, 1089, 10.1128/JCM.42.3.1089-1094.2004

Mugnaioli, 2006, CTX-M-type extended-spectrum β-lactamases in Italy: molecular epidemiology of an emerging countrywide problem, Antimicrob Agents Chemother, 50, 2700, 10.1128/AAC.00068-06

Pournaras, 2004, CTX-M-type β-lactamases affect community Escherichia coli treatment, Greece, Emerg Infect Dis, 10, 1163, 10.3201/eid1006.031031

Woodford, 2004, Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK, J Antimicrob Chemother, 54, 735, 10.1093/jac/dkh424

Pitout, 2007, Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates, Antimicrob Agents Chemother, 51, 1281, 10.1128/AAC.01377-06

Pitout, 2004, Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum β-lactamases: importance of community isolates with blaCTX-M genes, Clin Infect Dis, 38, 1736, 10.1086/421094

Ben Ami, 2006, Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital, Clin Infect Dis, 42, 925, 10.1086/500936

Rodriguez-Bano, 2006, Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge, Clin Infect Dis, 43, 1407, 10.1086/508877

Wiegand, 2007, Detection of extended-spectrum β-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures, J Clin Microbiol, 45, 1167, 10.1128/JCM.01988-06

Woodford, 2005, Molecular detection of antibiotic resistance: when and where?, J Antimicrob Chemother, 56, 259, 10.1093/jac/dki195

Tenover, 2007, Rapid detection and identification of bacterial pathogens using novel molecular technologies: infection control and beyond, Clin Infect Dis, 44, 418, 10.1086/510684

Thomson, 2001, Controversies about extended-spectrum and AmpC β-lactamases, Emerg Infect Dis, 7, 333, 10.3201/eid0702.010238

Stevenson, 2003, Detection of antimicrobial resistance by small rural hospital microbiology laboratories: comparison of survey responses with current NCCLS laboratory standards, Diagn Microbiol Infect Dis, 47, 303, 10.1016/S0732-8893(03)00092-0

Luzzaro, 2006, Performance in detection and reporting β-lactam resistance phenotypes in Enterobacteriaceae: a nationwide proficiency study in Italian laboratories, Diagn Microbiol Infect Dis, 55, 311, 10.1016/j.diagmicrobio.2006.01.017

2002

Spanu, 2006, Evaluation of the new VITEK 2 extended-spectrum β-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates, J Clin Microbiol, 44, 3257, 10.1128/JCM.00433-06

Pitout, 2003, Modification of the double-disk test for detection of enterobacteriaceae producing extended-spectrum and AmpC β-lactamases, J Clin Microbiol, 41, 3933, 10.1128/JCM.41.8.3933-3935.2003

Tzelepi, 2000, Detection of extended-spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes, J Clin Microbiol, 38, 542, 10.1128/JCM.38.2.542-546.2000

Glupczynski, 2007, Evaluation of a new selective chromogenic agar medium for detection of extended-spectrum β-lactamase-producing Enterobacteriaceae, J Clin Microbiol, 45, 501, 10.1128/JCM.02221-06

Ho, 2005, Detection and characterization of extended-spectrum β-lactamases among bloodstream isolates of Enterobacter spp in Hong Kong, 2000–2002, J Antimicrob Chemother, 55, 326, 10.1093/jac/dki010

Thomson, 1999, Use of microdilution panels with and without β-lactamase inhibitors as a phenotypic test for β-lactamase production among Escherichia coli, Klebsiella spp, Enterobacter spp, Citrobacter freundii, and Serratia marcescens, Antimicrob Agents Chemother, 43, 1393, 10.1128/AAC.43.6.1393

Arlet, 1995, Molecular characterisation by PCR-restriction fragment length polymorphism of TEM β-lactamases, FEMS Microbiol Lett, 134, 203

M'Zali, 1996, Detection of mutations conferring extended-spectrum activity on SHV β-lactamases using polymerase chain reaction single strand conformational polymorphism (PCR-SSCP), J Antimicrob Chemother, 37, 797, 10.1093/jac/37.4.797

Kim, 2000, Rapid discriminatory detection of genes coding for SHV β-lactamases by ligase chain reaction, Antimicrob Agents Chemother, 44, 1860, 10.1128/AAC.44.7.1860-1864.2000

Chanawong, 2001, Discrimination of SHV β-lactamase genes by restriction site insertion-PCR, Antimicrob Agents Chemother, 45, 2110, 10.1128/AAC.45.7.2110-2114.2001

Randegger, 2001, Real-time PCR and melting curve analysis for reliable and rapid detection of SHV extended-spectrum β-lactamases, Antimicrob Agents Chemother, 45, 1730, 10.1128/AAC.45.6.1730-1736.2001

Fluit, 2001, Molecular detection of antimicrobial resistance, Clin Microbiol Rev, 14, 836, 10.1128/CMR.14.4.836-871.2001

Sundsfjord, 2004, Genetic methods for detection of antimicrobial resistance, APMIS, 112, 815, 10.1111/j.1600-0463.2004.apm11211-1208.x

Pitout, 2004, Phenotypic and molecular detection of CTX-M-β-lactamases produced by Escherichia coli and Klebsiella spp, J Clin Microbiol, 42, 5715, 10.1128/JCM.42.12.5715-5721.2004

Batchelor, 2005, bla(CTX-M) genes in clinical salmonella isolates recovered from humans in England and Wales from 1992 to 2003, Antimicrob Agents Chemother, 49, 1319, 10.1128/AAC.49.4.1319-1322.2005

Pitout, 2007, Development and clinical validation of a molecular diagnostic assay to detect CTX-M-type β-lactamases in Enterobacteriaceae, Clin Microbiol Infect, 13, 291, 10.1111/j.1469-0691.2006.01645.x

Woodford, 2006, Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases, J Antimicrob Chemother, 57, 154, 10.1093/jac/dki412

Birkett, 2007, Real-time TaqMan PCR for rapid detection and typing of genes encoding CTX-M extended-spectrum β-lactamases, J Med Microbiol, 56, 52, 10.1099/jmm.0.46909-0

Naas, 2007, Identification of CTX-M-type extended-spectrum-β-lactamase genes using real-time PCR and pyrosequencing, Antimicrob Agents Chemother, 51, 223, 10.1128/AAC.00611-06

Ensor, 2007, A novel reverse-line hybridization assay for identifying genotypes of CTX-M-type extended-spectrum β-lactamases, J Antimicrob Chemother, 59, 387, 10.1093/jac/dkl505

Paterson, 2000, Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs), Clin Microbiol Infect, 6, 460, 10.1046/j.1469-0691.2000.00107.x

Lautenbach, 2001, Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes, Clin Infect Dis, 32, 1162, 10.1086/319757

Tumbarello, 2007, Predictors of mortality in bloodstream infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment, Antimicrob Agents Chemother, 51, 1987, 10.1128/AAC.01509-06

Lagace-Wiens, 2006, Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum β-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate, J Antimicrob Chemother, 57, 1262, 10.1093/jac/dkl102

Rice, 2001, Evolution and clinical importance of extended-spectrum β-lactamases, Chest, 119, 391S, 10.1378/chest.119.2_suppl.391S

Thomson, 2001, Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum β-lactamase-producing Enterobacteriaceae, Antimicrob Agents Chemother, 45, 3548, 10.1128/AAC.45.12.3548-3554.2001

Pangon, 1989, In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 β-lactamase, J Infect Dis, 159, 1005, 10.1093/infdis/159.5.1005

del Mar, 2005, Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection, Clin Microbiol Infect, 11, 540, 10.1111/j.1469-0691.2005.01184.x

Burgess, 2003, Clinical and microbiologic analysis of a hospital's extended-spectrum β-lactamase-producing isolates over a 2-year period, Pharmacotherapy, 23, 1232, 10.1592/phco.23.12.1232.32706

Endimiani, 2004, Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum β-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin, Clin Infect Dis, 38, 243, 10.1086/380645

Ho, 2002, Bacteremia caused by Escherichia coli producing extended-spectrum β-lactamase: a case-control study of risk factors and outcomes, Scand J Infect Dis, 34, 567, 10.1080/00365540210147516

Kim, 2002, Clinical implications of extended-spectrum β-lactamase-producing Klebsiella pneumoniae bacteraemia, J Hosp Infect, 52, 99, 10.1053/jhin.2002.1288

Kim, 2002, Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome, Antimicrob Agents Chemother, 46, 1481, 10.1128/AAC.46.5.1481-1491.2002

Kang, 2004, Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae, Infect Control Hosp Epidemiol, 25, 860, 10.1086/502310

Paterson, 2001, Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, J Clin Microbiol, 39, 2206, 10.1128/JCM.39.6.2206-2212.2001

Paterson, 2004, Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β-lactamases, Clin Infect Dis, 39, 31, 10.1086/420816

Zanetti, 2003, Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study, Antimicrob Agents Chemother, 47, 3442, 10.1128/AAC.47.11.3442-3447.2003

Lee, 2006, Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates, J Antimicrob Chemother, 58, 1074, 10.1093/jac/dkl381

Bin, 2006, Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli, Diagn Microbiol Infect Dis, 56, 351, 10.1016/j.diagmicrobio.2006.06.015

Chambers, 2001, The changing epidemiology of Staphylococcus aureus?, Emerg Infect Dis, 7, 178, 10.3201/eid0702.010204